Tectonic Therapeutic, Inc.
TECXNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $378.33M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $15.52$39.53
- Volume (live)
- -
- Avg. volume (3M)
- 228.72K
Tectonic Therapeutic (TECX) Stock Price & Financial Analysis
Tectonic Therapeutic Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $19.75 - $20.52 |
|---|---|
| 52-Week High | $39.53 |
| 52-Week Low | $15.52 |
| Open | $20.00 |
| Volume (last close) | 151.22K |
| Average Volume (3M) | 228.72K |
| 50-Day MA | $28.35 |
|---|---|
| 200-Day MA | $28.08 |
| 1-Year Change | +21.28% |
| Market Cap | 378.33M |
|---|---|
| Shares Outstanding | 18.96M |
| Price to Book (P/B) | 1.69 |
| EV/EBITDA | -2.12 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Tectonic Therapeutic at a Glance
As of the Oct 26, 2026 close, Tectonic Therapeutic (TECX) has a market capitalization of $378.33M.
As of its latest reported balance sheet, it holds $227.07M in cash and securities against $4.40M of debt, a net cash position of $222.67M.
Tectonic Therapeutic does not currently pay a dividend.
The share price is up 21.3% over the past year. At $19.95 (the Oct 26, 2026 close) it sits within its 52-week range of $15.52 to $39.53, below its 200-day moving average of $28.08.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $69.75, 249.6% above the Oct 26, 2026 close.
Frequently Asked Questions About Tectonic Therapeutic
What is the current stock price for TECX?
As of the Oct 26, 2026 close, TECX stock trades at $19.95. The 52-week range is $15.52–$39.53, with a day range of $19.75–$20.52.
What is the P/E ratio for TECX?
The P/E ratio (Price-to-Earnings) for TECX is shown in the Key Statistics section. This valuation metric helps compare Tectonic Therapeutic, Inc. to industry peers.
Does TECX pay dividends?
Tectonic Therapeutic does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TECX?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for TECX is Buy. The average 12-month price target is $69.75, a 249.6% upside from the Oct 26, 2026 close of $19.95.
What is the market cap of TECX?
As of the Oct 26, 2026 close, Tectonic Therapeutic's market capitalization is $378.3M, classifying it as a small-cap company. Tectonic Therapeutic operates in the Healthcare sector within the Biotechnology industry.